Clinical trial

Volrizon: Targeting Electrophysiology in Heart Failure Management PHARMA DEMO

Endovanta Therapeutics

What is it about?

Volrizon: a novel oral potassium channel modulator designed to help stabilize cardiac rhythm and reduce arrhythmic burden in patients with chronic heart failure.

Who is involved?